Auris Medical Holding Stock Net Income
Auris Medical Holding fundamentals help investors to digest information that contributes to Auris Medical's financial success or failures. It also enables traders to predict the movement of Auris Stock. The fundamental analysis module provides a way to measure Auris Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Auris Medical stock.
Auris |
Auris Medical Holding Company Net Income Analysis
Auris Medical's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Auris Medical Net Income | (8.2 M) |
Most of Auris Medical's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Auris Medical Holding is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, Auris Medical Holding reported net income of (8.2 Million). This is 102.4% lower than that of the Healthcare sector and 111.71% lower than that of the Biotechnology industry. The net income for all United States stocks is 101.44% higher than that of the company.
Auris Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Auris Medical's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Auris Medical could also be used in its relative valuation, which is a method of valuing Auris Medical by comparing valuation metrics of similar companies.Auris Medical is currently under evaluation in net income category among its peers.
Auris Fundamentals
| Return On Equity | -71.91 | |||
| Return On Asset | -21.99 | |||
| Current Valuation | 32.76 M | |||
| Shares Outstanding | 12.87 M | |||
| Shares Owned By Insiders | 5.45 % | |||
| Shares Owned By Institutions | 5.34 % | |||
| Number Of Shares Shorted | 362.97 K | |||
| Price To Earning | (1.05) X | |||
| Price To Book | 2.07 X | |||
| Price To Sales | 224.60 X | |||
| Revenue | 174.47 K | |||
| Gross Profit | 174.47 K | |||
| EBITDA | (5.26 M) | |||
| Net Income | (8.2 M) | |||
| Cash And Equivalents | 11.26 M | |||
| Cash Per Share | 0.88 X | |||
| Total Debt | 523.92 K | |||
| Debt To Equity | 0.03 % | |||
| Current Ratio | 3.83 X | |||
| Book Value Per Share | 1.47 X | |||
| Cash Flow From Operations | (4.84 M) | |||
| Short Ratio | 0.15 X | |||
| Earnings Per Share | (1.49) X | |||
| Beta | 1.37 | |||
| Market Capitalization | 39.19 M | |||
| Total Asset | 41 M | |||
| Retained Earnings | (164.84 M) | |||
| Working Capital | 31 M | |||
| Current Asset | 39 M | |||
| Current Liabilities | 8 M | |||
| Z Score | 38.8 |
Thematic Opportunities
Explore Investment Opportunities
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Consideration for investing in Auris Stock
If you are still planning to invest in Auris Medical Holding check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Auris Medical's history and understand the potential risks before investing.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |